Seattle hospital testing brain trauma drug

The Associated PressJuly 9, 2014 

— Patients who arrive unconscious with a head injury at Harborview Medical Center in Seattle may be given a drug being tested to prevent bleeding in the brain, even though they are unable to give their consent.

The hospital's chief trauma doctor, Dr. Eileen Bulger, says the drug known as TXA is already approved to stop internal bleeding. She's leading the study to determine if giving the drug as early as possible helps with traumatic brain injury.

The hospital is currently doing community outreach. Enrollment in the study won't begin until it gets approval from a review panel at the University of Washington.

The Seattle Times reports (http://bit.ly/VYdX4j ) that people can opt out by requesting a "NO-STUDY" bracelet (call 206-744-7724 or email pklotz@uw.edu).

The study at Harborview and nine other trauma centers will involve about 1,000 patients, and about 100 of those are at Harborview.

Information from: The Seattle Times, http://www.seattletimes.com

The Sun Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from profanity, hate speech, personal comments and remarks that are off point. Thank you for taking the time to offer your thoughts.

Commenting FAQs | Terms of Service